ArticleOphthalmology and therapy2026
Stereopsis and Vision-Related Quality of Life After Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment: A Prospective Cohort Study.
Article in Ophthalmology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of postoperative positioning on surgical and visual outcomes after pars plana vitrectomy for rhegmatogenous retinal detachment: a systematic review and meta-analysis.International journal of retina and vitreous · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTo determine whether macular involvement (on or off) at the time of rhegmatogenous retinal detachment (RRD) influences postoperative stereopsis and to explore factors associated with vision-related quality of life (VR-QoL).
methodsIn this prospective, single-centre observational cohort study conducted at the University Hospital of Tours, patients who underwent successful unilateral pars plana vitrectomy (PPV) for RRD were examined for 6 to 18 months postoperatively between June 2024 and March 2025. Surgical success was defined as anatomical reattachment at 3 months postoperatively. The following data were collected: intraoperative macular involvement, diplopia (orthoptic exam and optotype frame test), stereoacuity (The Netherlands Organization test), distance monocular best-corrected visual acuity, metamorphopsia (M-CHARTS), aniseikonia (New Aniseikonia Test), central retinal thickness and ellipsoid zone integrity on optical coherence tomography, retinal ghost vessels (autofluorescence), and VR-QoL assessed using the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25). Univariate analysis was performed to assess stereopsis, and factors associated with VR-QoL were investigated using multivariate linear regressions.
resultsForty-five patients were included [median age (range): 67 (46-82) years; women: 18 (40%), men: 27 (60%)]. Median duration from RRD repair and assessment was 10 (range 6-18) months. Stereoacuity was significantly worse in the macula-off group than in the macula-on group (p = 0.045). Multivariate analysis revealed that diplopia correlated negatively with the NEI VFQ-25 composite score (p = 0.004). No other variable showed any significant association with the NEI VFQ-25 composite score or its subscales (p > 0.05).
conclusionPostoperative stereopsis is significantly reduced in patients with macula-off RRD compared to those with macula-on RDD despite successful anatomical repair. However, neither stereopsis loss nor monocular qualitative or quantitative visual loss was significantly associated with VR-QoL in this cohort. Binocular diplopia, regardless of its mechanism, particularly affects VR-QoL, highlighting the importance of tailored postoperative assessment in patients with RRD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.